We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

VistaGen and WARF Sign License Agreement for Human Embryonic Stem Cell Technology

News   Dec 19, 2008

 
VistaGen and WARF Sign License Agreement for Human Embryonic Stem Cell Technology
 
 
 

RELATED ARTICLES

Platelet-Rich Plasma Does Not Promote Stem Cell-Mediated Cartilage Repair

News

Platelet-rich plasma reportedly improves pain relief and joint function, but it doesn't work the way we thought it did.

READ MORE

Effective Approach to Optimizing Medicinal Molecules Developed

News

Lobachevsky University scientists develop an effective approach to optimizing medicinal molecules, which will significantly accelerate and automate the process of prototype optimization to candidate molecules for subsequent preclinical testing.

READ MORE

Highly Effective and Selective Molecule Developed to Fight Malaria

News

A novel laboratory-synthesized molecule is a strong candidate for the development of a new antimalarial drug.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE